You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage III melanoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Stage III Trial in Shanghai (Toripalimab combined with Temozolomide)

Not yet recruiting
  • Melanoma Stage III
  • Toripalimab combined with Temozolomide
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 23, 2023

Melanoma Stage III Trial in North Sydney (Pembrolizumab, Lenvatinib)

Recruiting
  • Melanoma Stage III
  • North Sydney, New South Wales, Australia
    Melanoma Institute Australia
Oct 26, 2022

Melanoma, Complication Trial in Oslo (Suction drain)

Completed
  • Melanoma
  • Complication
  • Suction drain
  • Oslo, Norway
    Oslo University Hospital
Sep 1, 2022

Conservative Nodal Surgery of Stage III Melanoma With Low-burden

Recruiting
  • Melanoma Stage III
    • Seville, Spain
      Dermatology Department. University Hospital Virgen Macarena
    Jun 30, 2022

    Clinical Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage IIIA Cutaneous

    Recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +5 more
    • Jacksonville, Florida
    • +2 more
    Oct 21, 2022

    Improve Early Detection of Cancer Recurrence in High-Risk

    Recruiting
    • Stage III Melanoma
    • Stage IV Cutaneous Melanoma
      • Cleveland, Ohio
        Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
      Oct 6, 2022

      Melanoma Trial (pembrolizumab, )

      Active, not recruiting
      Has Results
      • Melanoma
      • pembrolizumab
      • placebo
      • (no location specified)
      Aug 18, 2022

      Melanoma Trial in Charlottesville (Excision of clinically detected lymph node metastasis before any systemic therapy, Excision

      Not yet recruiting
      • Melanoma
      • Excision of clinically detected lymph node metastasis before any systemic therapy
      • Excision of clinically detected lymph node metastasis after neoadjuvant systemic therapy
      • Charlottesville, Virginia
        Cancer Center at the University of Virginia
      Apr 20, 2023

      Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Shanghai (Endostar,

      Recruiting
      • Clinical Stage III Cutaneous Melanoma AJCC v8
      • Clinical Stage IV Cutaneous Melanoma AJCC v8
      • Shanghai, China
        Fudan University Shanghai Cancer Center
      Jun 17, 2023

      Stage III Melanoma, Stage IV Melanoma Trial in Los Angeles, Denver (TBX-3400)

      Recruiting
      • Stage III Melanoma
      • Stage IV Melanoma
      • TBX-3400
      • Los Angeles, California
      • +1 more
      May 1, 2022

      Unresectable Melanoma, Metastatic Melanoma, Stage III Melanoma Trial in Boston (Sargramostim (GM-CSF), Pembrolizumab

      Recruiting
      • Unresectable Melanoma
      • +3 more
      • Sargramostim (GM-CSF)
      • Pembrolizumab (anti-PD-1)
      • Boston, Massachusetts
      • +1 more
      Jul 6, 2022

      Melanoma Trial (GME751, Keytruda - EU, Keytruda - US)

      Not yet recruiting
      • Melanoma
      • (no location specified)
      Nov 22, 2023

      Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 Trial in Rochester (drug,

      Active, not recruiting
      • Metastatic Melanoma
      • +6 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 13, 2023

      Melanoma Stage IV, Melanoma Stage III, Immunetherapy Trial (nivolumab)

      Not yet recruiting
      • Melanoma Stage IV
      • +3 more
      • (no location specified)
      Dec 14, 2022

      Patients With Completely Resected High-risk Stage III Melanoma.

      Recruiting
      • Melanoma
      • Bursa, Gorukle, Turkey
      • +9 more
      Feb 28, 2022

      Melanoma Stage III, Melanoma Stage IV Trial in San Francisco (Binimetinib, Imatinib)

      Recruiting
      • Melanoma Stage III
      • Melanoma Stage IV
      • San Francisco, California
        University of California, San Francisco
      Dec 6, 2022

      Melanoma, Stage I, Melanoma, Stage II, Melanoma Stage III Trial (MSOT)

      Not yet recruiting
      • Melanoma, Stage I
      • +2 more
      • MSOT
      • (no location specified)
      Jul 15, 2022

      Stage III Malignant Melanoma of Skin AJCC V6, Stage IV Malignant Melanoma of Skin Trial in Santiago (TAPCells vaccine)

      Completed
      • Stage III Malignant Melanoma of Skin AJCC V6
      • Stage IV Malignant Melanoma of Skin
      • TAPCells vaccine
      • Santiago, RM, Chile
        Faculty of Medicine, University of Chile
      Nov 21, 2023

      Melanoma Trial in Sydney, Wollstonecraft, Melbourne (Dabrafenib, Trametinib, Pembrolizumab)

      Active, not recruiting
      • Melanoma
      • Sydney, New South Wales, Australia
      • +2 more
      Apr 4, 2022

      Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in

      Active, not recruiting
      • Stage III Cutaneous Melanoma AJCC v7
      • +4 more
      • Cryosurgery
      • +3 more
      • Rochester, Minnesota
        Mayo Clinic
      Jan 3, 2023

      Monitoring T Cell Responses in Melanoma, Lung and Other Cancer

      Recruiting
      • Clinical Stage III Cutaneous Melanoma AJCC v8
      • +9 more
      • Biospecimen Collection
      • Electronic Health Record Review
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Oct 4, 2023

      Melanoma Stage Iii, Melanoma Stage Iv, Melanoma Trial in Chapel Hill (Denosumab, Pembrolizumab, Nivolumab)

      Active, not recruiting
      • Melanoma Stage Iii
      • +4 more
      • Chapel Hill, North Carolina
        UNC Lineberger Comprehensive Cancer Center
      Jul 20, 2022

      Melanoma Stage III, Melanoma Stage IV, Inoperable Disease Trial in Tampa (Interleukin-2, Ipilimumab, Nivolumab)

      Recruiting
      • Melanoma Stage III
      • +2 more
      • Tampa, Florida
        Moffitt Cancer Center
      Dec 6, 2022

      Unresectable Melanoma, Metastatic Melanoma, Stage III NSCLC Trial in Louisville, New York (IOV-4001)

      Recruiting
      • Unresectable Melanoma
      • +3 more
      • IOV-4001
      • Louisville, Kentucky
      • +2 more
      Nov 21, 2022

      Melanoma, Skin Cancer Trial in Tampa (Panobinostat, Ipilimumab)

      Completed
      Has Results
      • Melanoma
      • Skin Cancer
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute
      Jan 18, 2023